Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Clinical Trial of CNS-targeted HAART (CIT2)

ClinicalTrials.gov ID: NCT00624195

Public ClinicalTrials.gov record NCT00624195. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-Targeted HAART

Study identification

NCT ID
NCT00624195
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
University of California, San Diego
Other
Enrollment
59 participants

Conditions and interventions

Conditions

Interventions

  • FDA Approved Antiretroviral Therapy (see list below) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2007
Primary completion
Jan 31, 2012
Completion
May 31, 2012
Last update posted
Apr 22, 2014

2007 – 2012

United States locations

U.S. sites
5
U.S. states
4
U.S. cities
5
Facility City State ZIP Site status
HIV Neurobehavioral Research Center, University of California San Diego San Diego California 92103
University of California, San Francisco San Francisco California 94110
Johns Hopkins University- School of Medicine Baltimore Maryland 21287
Washington University St Louis Missouri 63110
Mount Sinai Medical Center New York New York 10024

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00624195, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00624195 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →